Does TISLELIZUMAB-JSGR Cause Disease progression? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Disease progression have been filed in association with TISLELIZUMAB-JSGR. This represents 30.0% of all adverse event reports for TISLELIZUMAB-JSGR.
15
Reports of Disease progression with TISLELIZUMAB-JSGR
30.0%
of all TISLELIZUMAB-JSGR reports
2
Deaths
0
Hospitalizations
How Dangerous Is Disease progression From TISLELIZUMAB-JSGR?
Of the 15 reports, 2 (13.3%) resulted in death.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TISLELIZUMAB-JSGR. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does TISLELIZUMAB-JSGR Cause?
Off label use (9)
Anaemia (8)
Pneumonia (8)
Lymphadenopathy (7)
Thrombocytopenia (7)
Infusion related reaction (6)
Pyrexia (6)
Death (5)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)